Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Cowan, Andrew J"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kampouri E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Krantz EM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Xie H; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Ibrahimi SS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Kiem ES; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Sekhon MK; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Liang EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Portuguese A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Green DJ; Department of Medicine, University of Washington, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Albittar A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Huang JJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Pérez-Osorio AC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA., Jerome KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA., Zerr DM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Pediatrics, University of Washington, Seattle, WA., Boeckh MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Hill JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.
Publikováno v:
Blood [Blood] 2024 Aug 01; Vol. 144 (5), pp. 490-495.
Autor:
Banerjee R; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA. Electronic address: rahul.banerjee.md@gmail.com., Cowan AJ; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Ortega M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Missimer C; (Patient Advocate) Critical Thinking at Work, Seattle, WA., Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Oshima MU; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Salit RB; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Vo PT; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Lee CJ; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Mehta RS; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Kuderer NM; Advanced Cancer Research Group, Kirkland, WA., Shankaran V; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Lee SJ; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Su CT; Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Jul; Vol. 24 (7), pp. 446-454.e3. Date of Electronic Publication: 2024 Feb 23.
Autor:
Ho C; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA. Electronic address: carrho@uw.edu., Gopal AK; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Till BG; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Shadman M; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Lynch RC; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Cowan AJ; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Wu QV; Fred Hutchinson Cancer Center, Seattle, WA., Voutsinas J; Fred Hutchinson Cancer Center, Seattle, WA., Rasmussen HA; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA., Blue K; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA., Ujjani CS; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Cassaday RD; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Fromm JR; Department of Laboratory Medicine, Division of Hematopathology, University of Washington, Seattle, WA., Fang M; Fred Hutchinson Cancer Center, Seattle, WA., Smith SD; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Feb; Vol. 24 (2), pp. e33-e39.e1. Date of Electronic Publication: 2023 Oct 18.
Autor:
Gauthier J; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Bezerra ED; Department of Medicine and., Hirayama AV; Clinical Research Division and., Fiorenza S; Clinical Research Division and., Sheih A; Clinical Research Division and., Chou CK; Clinical Research Division and.; Department of Pediatrics, University of Washington, Seattle, WA., Kimble EL; Clinical Research Division and., Pender BS; Clinical Research Division and., Hawkins RM; Clinical Research Division and., Vakil A; Clinical Research Division and., Phi TD; Clinical Research Division and., Steinmetz RN; Clinical Research Division and., Jamieson AW; Clinical Research Division and., Bar M; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Cassaday RD; Clinical Research Division and.; Department of Medicine and., Chapuis AG; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Cowan AJ; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Green DJ; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Kiem HP; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Milano F; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Shadman M; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Till BG; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Riddell SR; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Maloney DG; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and., Turtle CJ; Clinical Research Division and.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA; and.; Department of Medicine and.
Publikováno v:
Blood [Blood] 2021 Jan 21; Vol. 137 (3), pp. 323-335.
Autor:
Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA., Green DJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA., Karami M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA., Becker PS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA., Tuazon S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA., Coffey DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA., Hyun TS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Pathology, University of Washington, Seattle, WA., Libby EN; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA., Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA., Holmberg LA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA. Electronic address: lholmber@fredhutch.org.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 Sep; Vol. 20 (9), pp. 602-609. Date of Electronic Publication: 2020 Apr 14.
Autor:
Voorhees PM; Levine Cancer Institute, Atrium Health, Charlotte, NC., Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA., Laubach J; Dana-Farber Cancer Institute, Boston, MA., Sborov DW; Huntsman Cancer Institute, School of Medicine, University of Utah, Salt Lake City, UT., Reeves B; Division of Hematology/Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Rodriguez C; Department of Hematology and Oncology, School of Medicine, Wake Forest University, Winston-Salem, NC., Chari A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Silbermann R; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Costa LJ; University of Alabama at Birmingham, Birmingham, AL., Anderson LD Jr; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX., Nathwani N; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, CA., Shah N; Department of Medicine, University of California San Francisco, San Francisco, CA., Efebera YA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Holstein SA; Division of Oncology & Hematology, University of Nebraska Medical Center, Omaha, NE., Costello C; Moores Cancer Center, University of California San Diego, La Jolla, CA., Jakubowiak A; University of Chicago Medical Center, Chicago, IL., Wildes TM; Section of Medical Oncology, Division of Oncology, School of Medicine, Washington University in St. Louis, St. Louis, MO., Orlowski RZ; Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Shain KH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Cowan AJ; Division of Medical Oncology, University of Washington, Seattle, WA., Murphy S; Janssen Scientific Affairs, LLC, Horsham, PA., Lutska Y; Janssen Scientific Affairs, LLC, Horsham, PA., Pei H; Janssen Research & Development, LLC, Titusville, NJ., Ukropec J; Janssen Global Medical Affairs, Horsham, PA; and., Vermeulen J; Janssen Research & Development, LLC, Leiden, The Netherlands., de Boer C; Janssen Research & Development, LLC, Leiden, The Netherlands., Hoehn D; Janssen Scientific Affairs, LLC, Horsham, PA., Lin TS; Janssen Scientific Affairs, LLC, Horsham, PA., Richardson PG; Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood [Blood] 2020 Aug 20; Vol. 136 (8), pp. 936-945.